IJDVL Close
 

Table 4: Prospects of new drugs as chemoprophylactic agents with advantages and disadvantages over rifampicin[34],[49],[53],[54],[55],[56],[57],[58]

Table 4: Prospects of new drugs as chemoprophylactic agents with advantages and disadvantages over rifampicin<sup>[34],[49],[53],[54],[55],[56],[57],[58]</sup>